Hetrocyclic compounds that are inhibitors of the enzyme DPP-IV
OwnerAnders B. Kanstrup, Christian Klarner Sams +3inventors
InventorsAnders B. Kanstrup, Christian Klarner Sams, Jane Marie Lundbeck, Lise Brown Christiansen, Andrew Neil Bowler
Life of this patent
Estimating the term…
Abstract
The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity. The present inhibitors are novel purine derivatives, attached at position 8 of the purine skeleton to a diamine.
Claims59
A compound of formula II
- 63
- A is C2-C6 alkylene;
- C2-C10 alkenylene;
- C3-C7 cycloalkylene;
- C3-C7 cycloheteroalkylene;
- arylene;
- heteroarylene;
- C1-C2 alkylene-arylene;
- arylene-C1-C2 alkylene;
- or C1-C2 alkylene-arylene-C1-C2 alkylene, wherein each alkylene, alkenylene, cycloalkylene, cycloheteroalkylene, arylene, or heteroarylene is optionally substituted with one or more R3 independently;
- R1 is aryl optionally substituted with one or more R2 independently, or heteroaryl optionally substituted with one or more R2 independently;
- R2 is H;
- C1-C7 alkyl;
- C2-C7 alkenyl;
- C2-C7 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- —NHCOR3;
- —NHSO2R3;
- —SR3;
- —SOR3;
- —SO2R3;
- —OCOR3;
- —CO2R4;
- —CON(R4)2;
- —CSN(R4)2;
- —NHCON(R4)2;
- —NHCSN(R4)2;
- —NHCONNH2;
- —SO2N(R4)2;
- —OR4;
- cyano;
- —CF3;
- nitro;
- or halogen, wherein each alkyl, alkenyl, alkynyl, cycloalkyl and cycloheteroalkyl is optionally substituted with one or more R3 independently;
- R3 is C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- aryl;
- heteroaryl;
- OR10;
- N(R10)2;
- or SR10, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, aryl and heteroaryl is optionally substituted with one or more R10 independently;
- R4 is H;
- C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- aryl;
- aryl-C1-C5 alkylene;
- heteroaryl;
- heteroaryl-C1-C5 alkylene, —CF3 or —CHF2, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, aryl-C1-C5 alkylene, heteroaryl, and heteroaryl-C1-C5 alkylene is optionally substituted with one or more R10 independently;
- R5 is H;
- C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- aryl;
- heteroaryl;
- —OR7;
- aryl-C1-C5 alkylene;
- heteroaryl-C1-C5 alkylene;
- —C1-C5-alkyl-C(═O)-aryl;
- —C1-C5-alkyl-C(═O)-heteroaryl;
- or —[(CH2)0-O]p—C1-C5 alkyl, wherein o and p are 1-3 independently, and wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, heteroaryl, aryl-C1-C5 alkylene, —C1-C5-alkyl-C(═O)-aryl, —C1-C5-alkyl-C(═O)-heteroaryl and heteroaryl-C1-C5 alkylene is optionally substituted with one or more R7 independently;
- R6 is H;
- C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- aryl;
- heteroaryl;
- aryl-C1-C5 alkylene;
- heteroaryl-C1-C5 alkylene;
- or C3-C7 cycloheteroalkyl-C1-C5 alkylene, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, C3-C7 cycloheteroalkyl-C1-C5 alkylene, aryl, heteroaryl, aryl-C1-C5 alkylene, and heteroaryl-C1-C5 alkylene is optionally substituted with one or more R10 independently;
- R7 is H;
- ═O;
- C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- aryl;
- heteroaryl;
- OR10;
- N(R10)2;
- SR10;
- cyano;
- hydroxy;
- halogen;
- —CF3;
- —CCl3;
- —OCF3;
- or —OCH3 wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, and heteroaryl is optionally substituted with one or more R10 independently;
- R8 is H;
- C1-C10 alkyl;
- C2-C10 alkenyl;
- C2-C10 alkynyl;
- C3-C7 cycloalkyl;
- C3-C7 cycloheteroalkyl;
- aryl;
- heteroaryl;
- OR10;
- N(R10)2;
- or SR10, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl, and heteroaryl is optionally substituted with one or more R10 independently;
- R9 is H;
- C1-C10 alkyl optionally substituted with one or more R8 independently;
- or halogen;
- R10 is H;
- —CF3;
- —CCl3;
- —OCF3;
- —OCH3;
- cyano;
- halogen;
- —OH, —COCH3;
- —CONH2;
- —CONHCH3;
- —CON(CH3)2;
- —NO2;
- —SO2NH2;
- or —SO2N(CH3)2;
- if two R4 or two R10 are attached to the same nitrogen they may be connected to form a 3- to 7-membered ring;
- R11 is H or C1-C6 alkyl optionally substituted with one or more R3 independently;
- R12 is H;
- C1-C6 alkyl optionally substituted with one or more R3 independently;
- or
- If A is C3-C7 cycloalkylene or C3-C7 cycloheteroalkylene R12 may be a valence bond between the nitrogen to which R12 is attached and one of the atoms in the cycloalkylene or cycloheteroalkylene;
- or a salt thereof with a pharmaceutically acceptable acid or base.
Dependencies are inferred from the claim text.